As President Donald Trump vowed to wage a "war on fraud" during his State of the Union address Tuesday, a panel of voters ...
Bearish investors fell to 36.9%, down from 38.1% last week, while bulls slumped to 34.5% from 38.5% last week. Those investors who are neutral on the six-month outlook for stocks jumped to 28.5% of ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for DATROWAY ® (datopotamab deruxtecan-dlnk) has been accepted and granted ...
TOKYO & BASKING RIDGE, N.J., February 03, 2026--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/NYSE: AZN) supplemental Biologics License Application (sBLA) for DATROWAY ® ...
NTPC consolidated in a long-term wedge since April 2025. After breaking above the wedge, it traded sideways in a rectangular range. The latest session delivered a strong breakout above this range on ...
STK-012 is an α/β biased IL-2 designed to specifically stimulate antigen activated T cells Results from an ongoing Phase 1a/1b to be presented at SITC Company will also present new preclinical data on ...
More state oversight of the City of Marion's finances could be on the horizon: the city may be declared to be in a state of "fiscal caution" by the state auditor. The mayor has formally requested a ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY ® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results